VEGFA and breast cancer: Likewise, Lee at al. found a reduced proliferation in the breast cancer cell line 4T1 and observed that BM-MSC-EVs down-regulate vascular endothelial growth factor (VEGF) expression in tumour cells, which results in the inhibition of angiogenesis both in vitro and in a subcutaneous xenograft [36].